株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CountryFocus:フィリピンの医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

発行 GlobalData 商品コード 301408
出版日 ページ情報 英文 199 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
CountryFocus:フィリピンの医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
出版日: 2016年08月16日 ページ情報: 英文 199 Pages
概要

フィリピンの総人口は2013年には9920万人に達し、世界第12位の人口大国となっています。出生率の高さと平均余命の改善が人口増大の主な要因となっています。一方で、高齢者人口の増加が政策立案者にとっての懸念事項となっています。フィリピンの医薬品市場は、2013年には43億米ドルに達し、さらに2020年には約80億米ドルにまで拡大する(その間の年平均成長率(CAGR)は9.4%)、と予測されています。

当レポートでは、フィリピンの医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、フィリピン経済・社会に関するマクロ的指標(医療インフラなど)、今後の市場機会と課題といった情報を取りまとめて、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野の概要
    • 主要企業
  • 医療機器市場
    • 市場概況
  • 市場の促進・阻害要因
    • 促進要因
    • 阻害要因

第4章 市場へのアクセス

  • 医療費償還・保険料支払者の状況
    • 医療制度の概要
    • 医療費償還の過程
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 医療サービスの価格動向
    • 薬価政策
  • 規制環境
    • 規制機関の概要
    • 医薬品の販売認証過程
    • 医療機器の新製品の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出入
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 環境問題
    • 医療従事者
  • 医療費支出
    • 概要
    • 医療費支出の主な要素
    • 公共/民間部門のシェア
    • 医薬品の研究開発(R&D)活動への支出額
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0060CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%.

These positive trends can primarily be attributed to -

  • An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
  • Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Philippines healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Market

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Major Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Price Trends in the Healthcare Sector
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. New Medical Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Pharmacy Regulations
    • 4.2.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Fiscal Deficit
    • 5.3.9. General Government Gross Debt
    • 5.3.10. External Debt
    • 5.3.11. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Share of Public and Private Sector
    • 5.6.4. Spending in Pharmaceutical R&D
  • 5.7. Trade Associations
    • 5.7.1. Pharmaceutical and Healthcare Association of the Philippines
    • 5.7.2. The Philippine Pharmaceutical Manufacturers Association
    • 5.7.3. The Philippine Pharmacist Association
    • 5.7.4. The Philippine Medical Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015
  • Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020
  • Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014
  • Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008
  • Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016
  • Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015
  • Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016
  • Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018
  • Table 11: Merck & Co., Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck & Co., 2016
  • Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016
  • Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016
  • Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015
  • Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2014
  • Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015
  • Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020
  • Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015
  • Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020
  • Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014
  • Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013
  • Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013
  • Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015
  • Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014
  • Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014
  • Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015
  • Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015
  • Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014
  • Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015
  • Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008-2015
  • Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013
  • Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014
  • Table 34: Demographics, Philippines, Population (million), 2008-2015
  • Table 35: Demographics, Philippines, Population (million), 2016-2020
  • Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015
  • Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020
  • Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015
  • Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020
  • Table 40: Demographics, Philippines, Births (per 1,000 population), 2008-2014
  • Table 41: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014
  • Table 42: Demographics, Philippines, Major Causes of Mortality ('000), 2013
  • Table 43: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015
  • Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2014
  • Table 45: Demographics, Philippines, Major Causes of Male Mortality ('000), 2013
  • Table 46: Demographics, Philippines, Major Causes of Female Mortality ('000), 2013
  • Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014
  • Table 48: Demographics, Philippines, Gender Ratio (M/F), 2008-2014
  • Table 49: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015
  • Table 50: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020
  • Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014
  • Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2015
  • Table 53: Demographics, Philippines, Major Diseases, Morbidity ('000), 2013
  • Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009
  • Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014
  • Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014
  • Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009
  • Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009
  • Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014
  • Table 60: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014
  • Table 61: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014
  • Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014
  • Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014
  • Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014
  • Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013
  • Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014
  • Table 67: Healthcare Market, Philippines, Major Trade Fairs, 2016

List of Figures

  • Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015
  • Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020
  • Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014
  • Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008
  • Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008
  • Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2016
  • Figure 7: Healthcare Market, Philippines, Healthcare System, 2016
  • Figure 8: Healthcare Market, Philippines, Drug Selection Procedure for Philippine National Drug Formulary, 2016
  • Figure 9: Healthcare Market, Philippines, Reimbursement Process, 2016
  • Figure 10: Healthcare Market, Philippines, PhilHealth Milestones, 2016
  • Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2016
  • Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016
  • Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015
  • Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2014
  • Figure 15: Healthcare Market, Philippines, Food and Drug Administration Structure, 2014
  • Figure 16: Philippines, Healthcare Market, Approval Process of New Drugs and Medical Devices, 2014
  • Figure 17: Healthcare Market, Philippines, Approval Process of Generic Drugs, 2016
  • Figure 18: Healthcare Market, Philippines, Bureau of Health Devices and Technology Structure, 2016
  • Figure 19: Healthcare Market, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2016
  • Figure 20: Healthcare Market, Philippines, Patent Approval Process, 2016
  • Figure 21: Healthcare Market, Philippines, Trademark Approval Process, 2016
  • Figure 22: Healthcare Market, Philippines, Clinical Trial Approval Process, 2014
  • Figure 23: Healthcare Market, Philippines, Procedure for Opening a Retail Pharmacy, 2014
  • Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2014
  • Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015
  • Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020
  • Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015
  • Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020
  • Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014
  • Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013
  • Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013
  • Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015
  • Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014
  • Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014
  • Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015
  • Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015
  • Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014
  • Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015
  • Figure 39: Economic Indicators, Philippines, External Debt ($bn), 2008-2015
  • Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013-2014
  • Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014
  • Figure 42: Demographics, Philippines, Population (million), 2008-2015
  • Figure 43: Demographics, Philippines, Population (million), 2016-2020
  • Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015
  • Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020
  • Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015
  • Figure 47: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020
  • Figure 48: Demographics, Philippines, Births (per 1,000 population), 2008-2014
  • Figure 49: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014
  • Figure 50: Demographics, Philippines, Major Causes of Mortality ('000), 2013
  • Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015
  • Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2014
  • Figure 53: Demographics, Philippines, Major Causes of Male Mortality ('000), 2013
  • Figure 54: Demographics, Philippines, Major Causes of Female Mortality ('000), 2013
  • Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014
  • Figure 56: Demographics, Philippines, Gender Ratio (M/F), 2008-2014
  • Figure 57: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015
  • Figure 58: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020
  • Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014
  • Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2015
  • Figure 61: Demographics, Philippines, Major Diseases, Morbidity ('000), 2013
  • Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009
  • Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014
  • Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014
  • Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009
  • Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009
  • Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014
  • Figure 68: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014
  • Figure 69: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014
  • Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014
  • Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014
  • Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014
  • Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013
  • Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014
  • Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2016
Back to Top